Bharat Parenterals Limited Share Price
Bharat Parenterals Limited Share Price Today
As of 5 Jul 2026, Bharat Parenterals Limited share price is ₹1,385.00. The stock opened at ₹1,353.00, compared to its previous close of ₹1,398.00. During today's trading session, Bharat Parenterals Limited share price moved in the range of ₹1,353.00 to ₹1,419.35, with an average price of ₹1,386.17 for the day. Looking at its last 52-week, the stock has touched a low of ₹880.25 and a high of ₹1,667.20.
Bharat Parenterals Limited Returns Calculator
Bharat Parenterals Limited Shareholder Returns
Bharat Parenterals Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Bharat Parenterals Limited Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹340.38 | ₹261.22 | ₹217.98 | ₹212.01 |
| Other Income | ₹11.62 | ₹4.68 | ₹11.74 | ₹7.78 |
| Total Revenue | ₹352.00 | ₹265.90 | ₹229.72 | ₹219.79 |
| Total Expenses | ₹385.95 | ₹247.17 | ₹206.17 | ₹191.92 |
| Profit Before Tax | -₹33.95 | ₹18.72 | ₹23.55 | ₹27.88 |
| Tax | ₹9.72 | ₹8.21 | ₹7.83 | ₹7.06 |
| Profit After Tax | -₹43.68 | ₹10.51 | ₹15.71 | ₹20.81 |
| EPS - Basic | -₹66.64 | ₹24.94 | ₹28.40 | ₹36.67 |
| EPS - Diluted | -₹66.64 | ₹24.94 | ₹28.40 | ₹36.67 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹33.95 | ₹18.72 | ₹23.55 | ₹27.88 |
| Income before WC changes | ₹6.54 | ₹34.05 | ₹32.35 | ₹32.73 |
| Change in Assets | -₹38.49 | -₹55.53 | -₹47.46 | -₹23.50 |
| Change in Liabilities | ₹15.30 | ₹26.24 | ₹45.56 | -₹4.63 |
| Change in WC | -₹23.19 | -₹29.29 | -₹1.90 | -₹28.13 |
| Cash flow from Operations | -₹27.25 | -₹4.71 | ₹21.66 | -₹1.07 |
| Cash flow from Investing | -₹137.39 | -₹104.78 | -₹77.82 | -₹6.63 |
| Cash flow from Financing | ₹156.37 | ₹110.43 | ₹60.60 | ₹9.42 |
| Total Cash Flow | -₹8.27 | ₹0.94 | ₹4.44 | ₹1.72 |
| Cash (Start of the year) | ₹8.71 | ₹7.84 | ₹3.40 | ₹1.68 |
| Cash (End of the year) | ₹0.44 | ₹8.78 | ₹7.84 | ₹3.40 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹293.01 | ₹242.04 | ₹166.06 | ₹82.32 |
| Current Assets | ₹355.52 | ₹262.00 | ₹184.28 | ₹143.74 |
| Total Assets | ₹648.53 | ₹504.04 | ₹350.34 | ₹226.06 |
| Current Liabilities | ₹219.30 | ₹189.83 | ₹119.80 | ₹41.53 |
| Net Current Asset | ₹136.21 | ₹72.18 | ₹64.49 | ₹102.20 |
| Non-Current Liabilities | ₹90.23 | ₹76.04 | ₹12.65 | ₹14.38 |
| Equity Capital | ₹339.00 | ₹238.17 | ₹217.90 | ₹170.14 |
| Total Equity & Liabilities | ₹648.53 | ₹504.04 | ₹350.34 | ₹226.06 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹304.13 | ₹257.98 | ₹217.98 | ₹212.01 |
| Other Income | ₹14.55 | ₹8.04 | ₹18.84 | ₹7.78 |
| Total Revenue | ₹318.68 | ₹266.02 | ₹236.82 | ₹219.79 |
| Total Expenses | ₹282.37 | ₹235.22 | ₹204.65 | ₹191.42 |
| Profit Before Tax | ₹36.32 | ₹30.80 | ₹32.17 | ₹28.37 |
| Tax | ₹9.86 | ₹8.21 | ₹7.83 | ₹7.06 |
| Profit After Tax | ₹26.45 | ₹22.59 | ₹24.34 | ₹21.30 |
| EPS - Basic | ₹40.36 | ₹38.81 | ₹42.14 | ₹37.11 |
| EPS - Diluted | ₹40.36 | ₹38.81 | ₹42.14 | ₹37.11 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹36.32 | ₹30.80 | ₹32.17 | ₹28.37 |
| Income before WC changes | ₹43.05 | ₹37.25 | ₹33.06 | ₹33.05 |
| Change in Assets | -₹20.69 | -₹47.52 | -₹71.27 | -₹46.05 |
| Change in Liabilities | ₹6.93 | ₹19.58 | ₹35.43 | -₹3.41 |
| Change in WC | -₹13.76 | -₹27.94 | -₹35.84 | -₹49.46 |
| Cash flow from Operations | ₹19.22 | -₹0.16 | -₹11.56 | -₹22.08 |
| Cash flow from Investing | -₹89.69 | -₹38.19 | -₹13.95 | ₹21.76 |
| Cash flow from Financing | ₹69.25 | ₹33.51 | ₹28.52 | ₹2.24 |
| Total Cash Flow | -₹1.21 | -₹4.84 | ₹3.01 | ₹1.93 |
| Cash (Start of the year) | ₹1.43 | ₹6.34 | ₹3.33 | ₹1.40 |
| Cash (End of the year) | ₹0.22 | ₹1.50 | ₹6.34 | ₹3.33 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹283.41 | ₹166.84 | ₹133.51 | ₹74.64 |
| Current Assets | ₹265.78 | ₹220.31 | ₹174.51 | ₹143.36 |
| Total Assets | ₹549.19 | ₹387.15 | ₹308.03 | ₹218.00 |
| Current Liabilities | ₹154.62 | ₹167.00 | ₹108.35 | ₹40.21 |
| Net Current Asset | ₹111.15 | ₹53.31 | ₹66.16 | ₹103.15 |
| Non-Current Liabilities | ₹7.74 | ₹6.54 | ₹8.62 | ₹11.64 |
| Equity Capital | ₹386.83 | ₹213.61 | ₹191.06 | ₹166.15 |
| Total Equity & Liabilities | ₹549.19 | ₹387.15 | ₹308.03 | ₹218.00 |
About Bharat Parenterals Limited
Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies. It has a manufacturing facility spread over 30,000 square feet (sq. ft.) area with a large batch-sized capacity for general: tablets, capsules, oral liquids, eye drops, ointments, lotions, creams, and others.
Bharat Parenterals Limited Financial Highlights
- Revenue: Bharat Parenterals Limited reported revenue of ₹354.97 crore in FY26 vs ₹352.00 crore in FY25. It showed an increase of 0.84% on a yearly basis.
- Operating Profit: Bharat Parenterals Limited reported an operating loss of ₹21.42 crore in FY26 vs ₹33.95 crore in FY25. It showed an increase of 36.91% on a year-on-year basis.
- Net Profit: Bharat Parenterals Limited reported a net loss of ₹27.31 crore in FY26 vs ₹43.68 crore in FY25. It showed an increase of 37.48% on a yearly basis.
Bharat Parenterals Limited Quarterly Result Highlights
- Bharat Parenterals Limited reported revenue of ₹103.25 crore in Mar 2026, compared with ₹66.52 crore in Dec 2025, representing an increase of 55.22% on a quarter-on-quarter (QoQ) basis.
- Bharat Parenterals Limited reported an operating loss of ₹8.37 crore in Mar 2026, compared with ₹8.28 crore in Dec 2025, representing a decrease of 1.09% on a quarter-on-quarter (QoQ) basis.
- Bharat Parenterals Limited reported a loss of ₹8.16 crore in Mar 2026, compared with ₹9.67 crore in Dec 2025, reflecting an increase of 15.62% on a QoQ basis.
- The earnings per share (EPS) of Bharat Parenterals Limited stood at ₹66.64 during Mar 2026.
Similar Stocks
FAQs on Bharat Parenterals Limited Share Price
What is Bharat Parenterals Limited share price today?
Bharat Parenterals Limited share price is ₹1,385.00 as on 03 Jul, 2026, 15:28 IST.
How has the Bharat Parenterals Limited share price performed in the past?
In the last 1 year, Bharat Parenterals Limited delivered a return of 15.48%. The Bharat Parenterals Limited share price hit a high of ₹1,667.20 and low of ₹880.25.
How much is the Mutual Fund shareholding in Bharat Parenterals Limited shares?
The Mutual Fund Shareholding in Bharat Parenterals Limited was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Bharat Parenterals Limited shares ?
The 52-week high and low of Bharat Parenterals Limited share is ₹1,667.20 and ₹880.25 as of 03 Jul, 2026.
What is the market cap of Bharat Parenterals Limited?
The market capitalisation of Bharat Parenterals Limited is ₹963.50 Crores as on 03 Jul, 2026.
What are the stock symbols of Bharat Parenterals Limited?
The stock symbol of Bharat Parenterals Limited is 541096 on the BSE, and the ISIN is INE365Y01019.
What was yesterday's closing price for Bharat Parenterals Limited shares ?
Bharat Parenterals Limited shares closed yesterday at ₹1,398.00 on BSE
How to buy Bharat Parenterals Limited shares?
To buy Bharat Parenterals Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Bharat Parenterals Limited shares on Holidays?
No, shares of Bharat Parenterals Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Bharat Parenterals Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Bharat Parenterals Limited?
The PE and PB ratio of Bharat Parenterals Limited is -35.29 and 2.99 respectively, as on 03 Jul, 2026, 15:28 IST.